Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa ( rIX‐FP ): A case report

  • López‐Jaime F
  • Fernández‐Bello I
  • Calavia‐Aranda E
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

KEY CLINICAL MESSAGE: In hemophilia patients undergoing cardiac surgery, ROTEM® and Quantra® viscoelastic tests are useful to monitor perioperative hemostatic status and a single dose of rIX-FP is safe and avoids any hemorrhagic or thrombotic complication. ABSTRACT: Cardiac surgery poses a high hemostatic risk in patients with hemophilia. We present the first case of an adult patient with hemophilia B on treatment with albutrepenonacog alfa (rIX-FP) who underwent surgery for acute coronary syndrome. Treatment with rIX-FP made it possible to perform the surgery safely.

Cite

CITATION STYLE

APA

López‐Jaime, F. J., Fernández‐Bello, I., Calavia‐Aranda, E., Reina‐Monsó, B., & Montaño, A. (2023). Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa ( rIX‐FP ): A case report. Clinical Case Reports, 11(6). https://doi.org/10.1002/ccr3.7439

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free